DASA (DASA3) Main Indicators
Basic Data - DASA3
| Company | DASA |
| Corporate Name | DIAGNOSTICOS DA AMERICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Medicina Diagnóstica. Hospitais e Oncologia. |
| Share | DASA3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 3.06 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 2.92 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | GPTW, IBRA, ICON, IGC, IGCT, IGNM, ISE, ITAG, SMLL |
| Updated 09/19/2024 | |
Relative Prices - DASA3
| Price/Earnings | -2.37 |
| Price/SBV | 0.32 |
| Price/Net Sales | 0.16 |
| Price/CFO | -4.01 |
| Price/FCF | -2.26 |
| Price/Total Assets | 0.08 |
| Price/EBIT | 2.21 |
| Price/Working Capital | 0.65 |
| Price/NCAV | -0.13 |
| EV/EBIT | 10.35 |
| EV/EBITDA | 4.54 |
| EV/Net Sales | 0.73 |
| EV/CFO | -18.75 |
| EV/FCF | -10.58 |
| EV/Total Assets | 0.38 |
| Company Market Cap | R$ 2.30 B |
| Enterprise Value | R$ 10.78 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 3.06 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 0.00% |
| Updated 09/19/2024 | |
Income Statement - DASA3
| Net Revenue | R$ 14.77 B |
| Gross Result | R$ 3.96 B |
| EBIT | R$ 1.04 B |
| Depreciation and Amortization | - R$ 1.33 B |
| EBITDA | R$ 2.37 B |
| Net Profit | - R$ 970.21 M |
| Net Profit/Share | - R$ 1.29 |
| Updated 08/14/2024 | |
| Net Revenue | R$ 3.96 B |
| Gross Result | R$ 1.14 B |
| EBIT | R$ 345.68 M |
| Depreciation and Amortization | - R$ 322.48 M |
| EBITDA | R$ 668.16 M |
| Net Profit | - R$ 104.62 M |
| Profit/Share | - R$ 0.14 |
| Updated 08/14/2024 | |
Price and Volume Behavior - DASA3
| Lowest Price 52 weeks | R$ 2.61 |
| Highest Price 52 weeks | R$ 12.85 |
| Variation 2024 | -66.63% |
| Variation 1 year | -73.28% |
| Variation 2 years(total) | -85.04% |
| Variation 2 years(yearly) | -61.17% |
| Variation 3 years(total) | -93.22% |
| Variation 3 years(yearly) | -59.15% |
| Variation 4 years(total) | -95.05% |
| Variation 4 years(yearly) | -52.80% |
| Variation 5 years(total) | -89.50% |
| Variation 5 years(yearly) | -36.22% |
| Average Daily Volume (3 months) | R$ 3.75 M |
| Updated 09/19/2024 | |
Returns and Margins - DASA3
| Return on Initial Tangible Capital | 6.77% |
| Return on Initial Invested Capital | 3.87% |
| Pre-Tax Return on Initial Tangible Capital | 10.25% |
| Pre-Tax Return on Initial Invested Capital | 5.86% |
| Return on Initial Shareholder´s Equity | -11.92% |
| Return on Initial Asset | -3.54% |
| Gross Margin | 26.79% |
| Net Margin | -6.57% |
| EBIT Margin | 7.05% |
| EBITDA Margin | 16.08% |
| Initial Asset Turnover | 0.54 |
| Financial Leverage | 3.93 |
| Liabilities/Net Worth | 2.93 |
| Net Debt/EBITDA | 3.57 |
| Updated 08/14/2024 | |
Balance Sheet - DASA3
| Cash and Cash Equivalents | R$ 2.87 B |
| Total Assets | R$ 28.13 B |
| Short-Term Debt | R$ 1.44 B |
| Long-Term Debt | R$ 9.91 B |
| Gross Debt | R$ 11.35 B |
| Net Debt | R$ 8.47 B |
| Shareholder´s Equity | R$ 7.15 B |
| Share Book Value | R$ 9.50 |
| Common Shares | 752,799,844 |
| Preferred Shares | 0 |
| Total | 752,799,844 |
| Common Shares in Treasury | 5,378,193 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 5,378,193 |
| Common Shares (Except Treasury) | 747,421,651 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 747,421,651 |
| Updated 08/14/2024 | |
Cash Flow - DASA3
| Operating Cash Flow | - R$ 574.92 M |
| Cash Flow from Investments | R$ 667.16 M |
| Financing Cash Flow | R$ 1.28 B |
| Increase (Reduction) in Cash and Equivalents | R$ 1.37 B |
| Updated 08/14/2024 | |
| Operating Cash Flow | - R$ 264.03 M |
| Cash Flow from Investments | - R$ 59.07 M |
| Financing Cash Flow | R$ 1.18 B |
| Increase (Reduction) in Cash and Equivalents | R$ 858.52 M |
| Updated 08/14/2024 | |
Experimental - DASA3
| CAPEX 3 months | - R$ 76.93 M |
| Free Cash Flow 3 months | - R$ 340.96 M |
| CAPEX 12 months | - R$ 443.50 M |
| Free Cash Flow 12 months | - R$ 1.02 B |
| Updated 08/14/2024 | |